Basilea Pharmaceutica Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|---|
| ARGX | argenx | Outperform |
4
|
329.80€ | Buy/Sell | 531.81€ | 36.14% | 10 | 19.60€B |
| GMAB | Genmab A/S | Outperform |
16
|
kr2.00k | Buy/Sell | kr2.71k | 31.37% | 14 | kr129.24B |
| REC | Recordati Industria Chimica e ... | Hold |
18
|
48.82€ | Buy/Sell | 48.61€ | 5.39% | 1 | 10.36€B |
| HIK | Hikma Pharmaceuticals PLC | Outperform |
18
|
£19.32 | Buy/Sell | £28.11 | 51.19% | 9 | £4.42B |
| ZEAL | Zealand Pharma A/S | Buy |
8
|
kr622.50 | Buy/Sell | kr357.00 | 30.92% | 2 | kr38.52B |
| ORNBV | Orion Oyj | Hold |
14
|
37.30€ | Buy/Sell | 42.52€ | 12.60% | 3 | 5.12€B |
| ALK B | ALK-Abelló A/S | Outperform |
13
|
kr154.90 | Buy/Sell | kr109.25 | 6.52% | 3 | kr33.91B |
| MOR | MorphoSys | Hold |
6
|
68.45€ | Buy/Sell | 28.78€ | -0.66% | 3 | 2.52€B |
| INDV | Indivior PLC | Buy |
14
|
£13.28 | Buy/Sell | £28.89 | 132.91% | 4 | £1.95B |
| ALM | Almirall | Outperform |
16
|
9.52€ | Buy/Sell | 11.39€ | 15.55% | 3 | 1.94€B |
| EVT | Evotec | Outperform |
14
|
9.54€ | Buy/Sell | 37.33€ | 67.71% | 4 | 1.73€B |
| COPN | Cosmo Pharmaceuticals N.V. | Buy |
12
|
CHF72.20 | Buy/Sell | CHF76.55 | 29.58% | 0 | CHF1.14B |
| FAE | Faes Farma | Hold |
18
|
3.67€ | Buy/Sell | 3.90€ | -0.54% | 0 | 1.09€B |
| PHM | Pharma Mar | Outperform |
13
|
36.02€ | Buy/Sell | 50.20€ | 33.26% | 1 | 536.95€M |
| NIOX | NIOX Group Plc | Buy |
6
|
£0.73 | Buy/Sell | £0.76 | 5.48% | 0 | £301.02M |
| DBV | DBV Technologies | Outperform |
5
|
1.30€ | Buy/Sell | 4.07€ | 207.69% | 1 | 115.65€M |
| MOLN | Molecular Partners | Outperform |
4
|
CHF3.40 | Buy/Sell | CHF9.50 | 175.00% | 1 | CHF110.77M |